These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 25707872)
1. Short prolactin profile for monitoring treatment in BH4 deficiency. Porta F; Ponzone A; Spada M Eur J Paediatr Neurol; 2015 May; 19(3):360-3. PubMed ID: 25707872 [TBL] [Abstract][Full Text] [Related]
2. Dopamine agonists in dihydropteridine reductase deficiency. Porta F; Mussa A; Concolino D; Spada M; Ponzone A Mol Genet Metab; 2012 Apr; 105(4):582-4. PubMed ID: 22325981 [TBL] [Abstract][Full Text] [Related]
3. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels. Ogawa A; Kanazawa M; Takayanagi M; Kitani Y; Shintaku H; Kohno Y Brain Dev; 2008 Jan; 30(1):82-5. PubMed ID: 17590551 [TBL] [Abstract][Full Text] [Related]
4. Long-term safety and effectiveness of pramipexole in tetrahydrobiopterin deficiency. Porta F; Ponzone A; Spada M Eur J Paediatr Neurol; 2016 Nov; 20(6):839-842. PubMed ID: 27562098 [TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemia, a tool in treatment control of tetrahydrobiopterin deficiency: endocrine studies in an affected girl. Birnbacher R; Scheibenreiter S; Blau N; Bieglmayer C; Frisch H; Waldhauser F Pediatr Res; 1998 Apr; 43(4 Pt 1):472-7. PubMed ID: 9545000 [TBL] [Abstract][Full Text] [Related]
6. Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency. Porta F; Mussa A; Concolino D; Spada M; Ponzone A Neurology; 2009 Aug; 73(8):633-7. PubMed ID: 19704083 [TBL] [Abstract][Full Text] [Related]
7. [Malignant phenylketonuria caused by biopterin synthetase deficiency. Study of neuromediator catabolites in the cerebrospinal fluid during treatment]. Malpuech G; Guyon A; Demeocq F; Piton A; Boespflug O; Vanlieferinghen P Arch Fr Pediatr; 1984 Jan; 41(1):5-8. PubMed ID: 6202269 [TBL] [Abstract][Full Text] [Related]
8. BH4 treatment in BH4-responsive PKU patients: preliminary data on blood prolactin concentrations suggest increased cerebral dopamine concentrations. van Vliet D; Anjema K; Jahja R; de Groot MJ; Liemburg GB; Heiner-Fokkema MR; van der Zee EA; Derks TG; Kema IP; van Spronsen FJ Mol Genet Metab; 2015 Jan; 114(1):29-33. PubMed ID: 25466353 [TBL] [Abstract][Full Text] [Related]
9. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. Fine SA; Frohman LA J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585 [TBL] [Abstract][Full Text] [Related]
10. Target Prolactin Range in Treatment of Tetrahydrobiopterin Deficiency. Porta F; Ponzone A; Spada M J Pediatr; 2016 Jan; 168():236-239.e1. PubMed ID: 26515614 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis, treatment and follow-up of patients with tetrahydrobiopterin deficiency in Shandong province, China. Han B; Zou H; Han B; Zhu W; Cao Z; Liu Y Brain Dev; 2015 Jun; 37(6):592-8. PubMed ID: 25304915 [TBL] [Abstract][Full Text] [Related]
12. Screening for tetrahydrobiopterin deficiency among hyperphenylalaninemia patients in Southern China. Ye J; Liu X; Ma X; Zhang Y; Huang X; Chen R; Gu X Chin Med J (Engl); 2002 Feb; 115(2):217-21. PubMed ID: 11940335 [TBL] [Abstract][Full Text] [Related]
14. L-DOPA attenuates prolactin secretion in response to isolation stress in Holstein steers. Kasuya E; Yayou K; Sutoh M Anim Sci J; 2013 Jul; 84(7):562-8. PubMed ID: 23607456 [TBL] [Abstract][Full Text] [Related]
15. Prolactin response to acute administration of different L-dopa plus decarboxylase inhibitors in Parkinson's disease. Ruggieri S; Falaschi P; Baldassarre M; D'Urso R; De Giorgio G; Rocco A; Agnoli A Neuropsychobiology; 1982; 8(2):102-8. PubMed ID: 7070643 [TBL] [Abstract][Full Text] [Related]
16. Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease. Bell RD; Carruth A; Rosenberg RN; Boyar RM J Clin Endocrinol Metab; 1978 Oct; 47(4):807-11. PubMed ID: 45469 [TBL] [Abstract][Full Text] [Related]
17. Early replacement therapy in a first Japanese case with autosomal recessive guanosine triphosphate cyclohydrolase I deficiency with a novel point mutation. Sato H; Uematsu M; Endo W; Nakayama T; Kobayashi T; Hino-Fukuyo N; Sakamoto O; Shintaku H; Kure S Brain Dev; 2014 Mar; 36(3):268-71. PubMed ID: 23660475 [TBL] [Abstract][Full Text] [Related]